Less Ads, More Data, More Tools Register for FREE

Pin to quick picksJames Fisher and Sons Regulatory News (FSJ)

Share Price Information for James Fisher and Sons (FSJ)

Share Price is delayed by 15 minutes
Get Live Data
498.00    -16.00 (-3.11%)
Bid:
498.00
Ask:
506.00
Spread: 8.00 (1.606%)
Market Cap: £251.41m
FSJ Live PriceLast checked at - London Stock Exchange

Intraday James Fisher and Sons Share Chart

AGM and Interim Management Statement

6 May 2010 07:00

RNS Number : 4124L
Fisher (James) & Sons PLC
06 May 2010
 



 

 

 

James Fisher and Sons plc

 

AGM and Interim Management Statement

 

 

James Fisher and Sons plc today issues the following Interim Management Statement for the period from 1 January to date. This will be read out by the Chairman at today's Annual General Meeting.

 

Trading in 2010 to date has been to management expectations and in pattern broadly similar to the second half of 2009. The Specialist Technical division has continued to trade strongly. In January 2010 we announced the acquisition of Australian Commercial Marine Pty Ltd for £3 million which is expected to enhance FenderCare's growth in Australia and the Asia Pacific region. The Nuclear cluster, including the Faber acquisition, continues to trade to management expectations meeting the Company's criteria for profitable growth.

 

In Marine Oil, the volumes carried in the first three months were slightly improved over the latter part of 2009. However, there has been no improvement so far in the spot market rates for our clean petroleum product tankers, which is also important to ensure the recovery of this division.

 

Trading in the Offshore market is skewed towards the summer months so at present it is more relevant to talk in terms of trends and order books than actual results. So far our Norwegian activities look well set and in April we completed the acquisition of GMC Produkt AS for £11.5 million cash and £0.3 million in net debt to strengthen significantly our lifting business. This was funded from internal resources. As in 2009, in Scotland and in the UK sector of the North Sea generally, our activities have started more slowly. The Aberdeen based RMSpumptools is trading well because it is more focused on the newer, developing oil regions. The Norwegian property has now been completed and good progress is being made towards its sale and lease back.

 

In the early months of the year our Submarine Rescue Operations have had some success both in terms of operational performance on exercise and by gaining some useful medium sized orders, but so far no major new "national" order has been forthcoming.

 

Owing to the strength of its Marine Services divisions, the Company has been able to more than compensate for the downturn in its Marine Oil division, caused by the global economic recession. Since the turn of the year many shipping sectors have shown significant signs of recovery but not so far our clean petroleum product tankers. When this occurs, which it should with greater economic activity, it will have a beneficial effect on James Fisher's results. Overall the Company remains well placed to continue its proven track record of producing good growth and value for our shareholders.

 

Contacts

 

James Fisher and Sons plc

 

Tim Harris

Chairman

020 7614 9508

Financial Dynamics

 

Richard Mountain

Sophie Kernon

020 7269 7291

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
AGMAAMATMBAMBIM
Date   Source Headline
15th Dec 20215:36 pmRNSBLOCK LISTING SIX MONTHLY RETURN
1st Dec 20215:22 pmRNSHolding(s) in Company
18th Nov 202110:25 amRNSHolding(s) in Company
2nd Nov 20217:00 amRNSSale of James Fisher Testing Services for £5.7m
1st Nov 20215:23 pmRNSDirector/PDMR Shareholding
25th Oct 20217:00 amRNSTrading update
22nd Oct 20218:00 amRNSAppointment of non-executive director
15th Sep 20211:26 pmRNSDirector/PDMR Shareholding
7th Sep 20217:00 amRNSHalf year results for the 6 months ended 30 Jun 21
1st Jul 20217:00 amRNSSale of Paladin for US$17.3m
29th Jun 20217:00 amRNSCapital Markets Event & Pre Close Trading Update
15th Jun 20213:51 pmRNSBLOCK LISTING SIX MONTHLY RETURN
2nd Jun 20214:16 pmRNSDirector/PDMR Shareholding
30th Apr 202111:59 amRNSDirector Declaration
29th Apr 20212:01 pmRNSResult of Annual General Meeting
29th Apr 20217:00 amRNSAGM Trading Statement
20th Apr 20217:00 amRNSAppointment of Chief Financial Officer
13th Apr 202111:32 amRNSWithdrawal of Annual General Meeting Resolution
9th Apr 202110:18 amRNSDirector/PDMR Shareholding
8th Apr 20213:58 pmRNSDirector/PDMR Shareholding
6th Apr 20213:48 pmRNSDirector/PDMR Shareholding
1st Apr 20217:00 amRNSTotal Voting Rights and Share Capital
29th Mar 20217:00 amRNSDirectorate Change
23rd Mar 202112:58 pmRNSAnnual Report and Notice of AGM posted
19th Mar 20211:17 pmRNSHolding(s) in Company
11th Mar 20217:00 amRNSResults for the year ended 31 December 2020
25th Feb 202110:42 amRNSNotification of FY Results Date
25th Jan 20217:00 amRNSAngus Cockburn appointed as Chairman
7th Jan 20217:00 amRNSPost close trading update
18th Dec 20204:41 pmRNSSecond Price Monitoring Extn
18th Dec 20204:35 pmRNSPrice Monitoring Extension
15th Dec 202011:18 amRNSBLOCK LISTING SIX MONTHLY RETURN
11th Nov 20207:00 amRNSDirector/PDMR Shareholding
9th Nov 20205:25 pmRNSTotal Voting Rights
6th Nov 20207:00 amRNSTrading Update
2nd Nov 20207:00 amRNSTotal Voting Rights
23rd Oct 20209:48 amRNSDirector/PDMR Shareholding
6th Oct 20203:58 pmRNSDirector/PDMR Shareholding
2nd Oct 20207:00 amRNSRoyal Navy contract award
21st Sep 20204:00 pmRNSDirector/PDMR Shareholding
25th Aug 20207:00 amRNSHalf-year results
24th Jul 202012:00 pmRNSDirector/PDMR Shareholding
7th Jul 20207:00 amRNSHalf year post close trading update
24th Jun 202012:02 pmRNSPrice Monitoring Extension
15th Jun 20207:00 amRNSBLOCK LISTING SIX MONTHLY RETURN
14th May 20204:41 pmRNSSecond Price Monitoring Extn
14th May 20204:36 pmRNSPrice Monitoring Extension
30th Apr 20202:51 pmRNSDisclosure of Rights Attached to Equity Shares
30th Apr 20202:49 pmRNSResult of AGM
30th Apr 20207:00 amRNSAGM trading statement & Covid-19 update

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.